• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因子 V-Short 中的 preAR2 区域(1458-1492)对于与蛋白 S 的协同 TFPIα 辅因子活性以及包含 FV-Short、蛋白 S 和 TFPIα 的三分子因子 Xa 抑制性复合物的组装至关重要。

The preAR2 region (1458-1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα.

机构信息

Department of Translational Medicine, Lund University, University Hospital, Malmö, Sweden.

出版信息

J Thromb Haemost. 2022 Jan;20(1):58-68. doi: 10.1111/jth.15547. Epub 2021 Oct 19.

DOI:10.1111/jth.15547
PMID:34623729
Abstract

BACKGROUND

Factor V-Short (FV756-1458) is a natural splice variant in which 702 residues are deleted from the B domain. It exposes an acid region (AR2; 1493-1537) that binds tissue factor pathway inhibitor alpha (TFPIα). Protein S also interacts with TFPIα and serves as TFPIα-cofactor in factor Xa (FXa) inhibition. FV-Short and protein S function as synergistic TFPIα-cofactors in inhibition of FXa. FV810-1492 is an artificial FV-Short variant that cannot synergize with protein S as TFPIα cofactor even though it contains AR2 and binds TFPIα.

OBJECTIVE

To elucidate the mechanisms for the synergism between FV756-1458 and protein S as TFPIα cofactors.

METHODS

Four FV-Short variants were created, FV756-1458 and FV712-1458 contained the preAR2 region (1458-1492), whereas FV810-1492 and FV713-1492 lacked this region. The synergistic TFPIα cofactor activity between FV-Short variants and protein S was analyzed by FXa-inhibition. A microtiter-based assay tested binding between FV-Short variants, protein S, and TFPIα.

RESULTS

The two preAR2-containing FV-Short variants were active as synergistic TFPIα cofactors, whereas the other two were inactive. All variants bound to TFPIα. None of the FV-Short variants bound directly to protein S. The combination of TFPIα and preAR2-containing FV-Short variants bound protein S, whereas TFPIα together with the preAR2-minus variants did not. Protein S potentiated TFPIα-binding to the preAR2-containing variants and binding between TFPIα and protein S was stimulated only by the preAR2-containing variants.

CONCLUSION

The preAR2 region is demonstrated to be crucial for the synergistic TFPIα-cofactor activity between FV-Short and protein S and for the assembly of a trimolecular FXa-inhibitory complex comprising FV-Short, protein S, and TFPIα.

摘要

背景

因子 V-Short(FV756-1458)是一种天然剪接变异体,其中 B 结构域缺失了 702 个残基。它暴露了一个酸性区域(AR2;1493-1537),该区域可与组织因子途径抑制剂 alpha(TFPIα)结合。蛋白 S 也与 TFPIα相互作用,并作为 FXa 抑制因子 Xa(FXa)的 TFPIα 辅助因子。FV-Short 和蛋白 S 作为协同 TFPIα 辅助因子,共同抑制 FXa。FV810-1492 是一种人工 FV-Short 变体,尽管它含有 AR2 并与 TFPIα 结合,但不能与蛋白 S 协同作为 TFPIα 辅助因子。

目的

阐明 FV756-1458 和蛋白 S 作为 TFPIα 辅助因子协同作用的机制。

方法

构建了四种 FV-Short 变体,FV756-1458 和 FV712-1458 包含前 AR2 区(1458-1492),而 FV810-1492 和 FV713-1492 缺失该区域。通过 FXa 抑制分析,研究了 FV-Short 变体与蛋白 S 之间协同 TFPIα 辅助因子的活性。基于微孔板的测定法检测了 FV-Short 变体、蛋白 S 和 TFPIα 之间的结合。

结果

两种含有前 AR2 的 FV-Short 变体作为协同 TFPIα 辅助因子具有活性,而另外两种变体则没有活性。所有变体均与 TFPIα 结合。FV-Short 变体均不直接与蛋白 S 结合。TFPIα 与含有前 AR2 的 FV-Short 变体结合,而蛋白 S 则与不含前 AR2 的变体结合。蛋白 S 增强了 TFPIα 与含有前 AR2 的变体的结合,并且仅含有前 AR2 的变体刺激了 TFPIα 与蛋白 S 之间的结合。

结论

证明前 AR2 区域对于 FV-Short 和蛋白 S 之间的协同 TFPIα 辅助因子活性以及包含 FV-Short、蛋白 S 和 TFPIα 的三分子 FXa 抑制性复合物的组装至关重要。

相似文献

1
The preAR2 region (1458-1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα.因子 V-Short 中的 preAR2 区域(1458-1492)对于与蛋白 S 的协同 TFPIα 辅因子活性以及包含 FV-Short、蛋白 S 和 TFPIα 的三分子因子 Xa 抑制性复合物的组装至关重要。
J Thromb Haemost. 2022 Jan;20(1):58-68. doi: 10.1111/jth.15547. Epub 2021 Oct 19.
2
A hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S.FV 短链 B 结构域中的疏水性补丁(PLVIVG;1481-1486)对于其与蛋白 S 的协同 TFPIα 辅因子活性以及 FXa 抑制性复合物的形成至关重要,该复合物包含 FV 短链、TFPIα 和蛋白 S。
J Thromb Haemost. 2022 May;20(5):1146-1157. doi: 10.1111/jth.15690. Epub 2022 Mar 16.
3
Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors.因子V短型和蛋白S作为协同组织因子途径抑制剂(TFPIα)辅因子。
Res Pract Thromb Haemost. 2017 Dec 20;2(1):114-124. doi: 10.1002/rth2.12057. eCollection 2018 Jan.
4
The TFPIα C-terminal tail is essential for TFPIα-FV-short-protein S complex formation and synergistic enhancement of TFPIα.组织因子途径抑制物 α C 端尾部对于 TFPIα-FV-short 蛋白 S 复合物的形成和协同增强 TFPIα 是必需的。
J Thromb Haemost. 2023 Dec;21(12):3568-3580. doi: 10.1016/j.jtha.2023.09.003. Epub 2023 Sep 20.
5
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.新型因子 V 异构体、组织因子途径抑制物α 和蛋白 S 对凝血的调控作用的新见解。
J Thromb Haemost. 2017 Jul;15(7):1241-1250. doi: 10.1111/jth.13665.
6
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short.新型功能性试验检测 Protein S 与 FV-Short 协同作用下对 TFPIα 辅因子活性的影响
J Thromb Haemost. 2019 Apr;17(4):585-595. doi: 10.1111/jth.14405. Epub 2019 Mar 11.
7
Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.在 TFPIα 的存在下,因子 V 在血浆中具有抗凝活性:FV1 和 FV2 之间的差异。
Thromb Haemost. 2018 Jul;118(7):1194-1202. doi: 10.1055/s-0038-1656549. Epub 2018 Jun 4.
8
Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.TFPIα 对因子 V 和因子 V 短片段的调节:B 结构域蛋白水解与结合的关系。
J Biol Chem. 2021 Jan-Jun;296:100234. doi: 10.1074/jbc.RA120.016341. Epub 2021 Jan 7.
9
The C-terminus of tissue factor pathway inhibitor-α inhibits factor V activation by protecting the Arg cleavage site.组织因子途径抑制物-α 的 C 末端通过保护 Arg 裂解位点来抑制因子 V 的激活。
J Thromb Haemost. 2017 Jan;15(1):140-149. doi: 10.1111/jth.13559. Epub 2016 Dec 3.
10
Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.因子V具有针对凝血早期阶段的抗凝辅因子活性。
J Biol Chem. 2017 Jun 2;292(22):9335-9344. doi: 10.1074/jbc.M116.769570. Epub 2017 Apr 18.

引用本文的文献

1
Cryo-EM structure of coagulation factor Va bound to activated protein C.与活化蛋白C结合的凝血因子Va的冷冻电镜结构
Blood. 2025 Jun 26;145(26):3166-3177. doi: 10.1182/blood.2025028476.
2
Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach.采用数学建模方法研究 concizumab 在甲型血友病中的下游效应。
J Thromb Haemost. 2025 Feb;23(2):480-491. doi: 10.1016/j.jtha.2024.10.028. Epub 2024 Nov 12.
3
The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding.
凝血因子V常见的VTE保护性G单倍型增加了凝血因子V短链、组织因子途径抑制物(TFPI)的功能以及出血风险。
Blood Adv. 2025 Jan 14;9(1):132-142. doi: 10.1182/bloodadvances.2024014020.
4
Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation.组织因子途径抑制剂 - 辅因子依赖性调节凝血的启动。
Curr Opin Hematol. 2024 Nov 1;31(6):315-320. doi: 10.1097/MOH.0000000000000838. Epub 2024 Aug 26.
5
Factor V variants in bleeding and thrombosis.出血和血栓形成中的凝血因子V变体
Res Pract Thromb Haemost. 2024 Jan 26;8(1):102330. doi: 10.1016/j.rpth.2024.102330. eCollection 2024 Jan.
6
Structural architecture of the acidic region of the B domain of coagulation factor V.凝血因子 V B 结构域酸性区的结构架构。
J Thromb Haemost. 2024 Mar;22(3):709-714. doi: 10.1016/j.jtha.2023.11.003. Epub 2023 Nov 23.
7
Cryo-EM structure of coagulation factor V short.凝血因子 V 短链的冷冻电镜结构。
Blood. 2023 Jun 29;141(26):3215-3225. doi: 10.1182/blood.2022019486.
8
Platelet tissue factor pathway inhibitor-α dampens cardiac thrombosis and associated fibrosis in mice.血小板组织因子途径抑制剂-α可抑制小鼠心脏血栓形成和相关纤维化。
J Thromb Haemost. 2023 Mar;21(3):639-651. doi: 10.1016/j.jtha.2022.11.034. Epub 2022 Dec 22.
9
Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI.在流动条件下凝血过程中抑制血小板表面结合蛋白 I:TFPI。
Biophys J. 2023 Jan 3;122(1):99-113. doi: 10.1016/j.bpj.2022.11.023. Epub 2022 Nov 21.
10
Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress.国际血栓与止血学会(ISTH)2022年大会的图说前沿胶囊。
Res Pract Thromb Haemost. 2022 Jul 6;6(5):e12747. doi: 10.1002/rth2.12747. eCollection 2022 Jul.